Health Trials

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer

2

Review clinical trials related to Locoregionally Recurrent Hormone-receptor Positive Breast Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 1 Study of 68Ga-R11228 and 177Lu-R11228 in Breast Cancer

A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer.

Participants needed: 62
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Radionetics OncologyUpdated: Apr 13, 2026Locations: 7
Eligibility criteria

Pathologically confirmed estrogen and/or progesterone receptor (ER/PR) positive... [+11]

Study participant has not recovered from clinically significant adverse event(s)... [+12]

Read more
Status: Recruiting

Study of 68Ga-R10602

A phase 1 imaging study of 68Ga-R10602 in hormone-receptor positive breast cancer.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Radionetics OncologyUpdated: Mar 13, 2026Locations: 6
Eligibility criteria

Population 1: Pathologically confirmed ER and/or PR positive, locoregionally rec... [+11]

Received a radionuclide within a period of less than 10 physical half-lives of t... [+8]

Read more